← Open Payments lookup

LAILA MADHANI: Open Payments

NPI 1578957254 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,375 in 54 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $405 · 2025 $1,375

Food & beverage: $1,375
CompanyPaymentsAmount
Amgen Inc.6$233
AstraZeneca Pharmaceuticals LP9$152
Recor Medical Inc4$135
Otsuka America Pharmaceutical, Inc.4$116
Novo Nordisk Inc4$107
Mallinckrodt Hospital Products Inc.4$91
Calliditas Therapeutics US Inc.4$90
Ardelyx, Inc.3$72
OPKO Pharmaceuticals, LLC3$60
Alexion Pharmaceuticals, Inc.2$50

Products named: KRYSTEXXA, FARXIGA, Paradise Ultrasound Renal Denervation System, JYNARQUE, Ozempic, ACTHAR, TARPEYO, IBSRELA.

Industry payments across TX — which companies pay providers there.